Cellular phagocytic studies in rheumatoid arthritis patients treated with levamisole.
AUTOR(ES)
Wynne, K M
RESUMO
A simple method is described which allows sequential monitoring of the endocytic activity of blood and synovial fluid cells from rheumatoid arthritis patients undergoing therapy with levamisole. Evidence of immediate (24 hours) and long-term (5-7 weeks) cellular phagocytic enhancement is presented.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1000733Documentos Relacionados
- Neutropenia during treatment of rheumatoid arthritis with levamisole.
- Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole.
- Rectal ulcer associated with levamisole.
- Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine.
- Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis.
